A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients with metastatic pancreas cancer (Q46396079)
Jump to navigation
Jump to search
scientific article published in April 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients with metastatic pancreas cancer |
scientific article published in April 2005 |
Statements
1 reference
A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients with metastatic pancreas cancer (English)
1 reference
Yutaka Takahashi
1 reference
Masayoshi Mai
1 reference
Norio Sawabu
1 reference
Kenji Nishioka
1 reference
1 April 2005
1 reference
1 reference
30
1 reference
3
1 reference
206-210
1 reference
Identifiers
1 reference